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Please be advised that the proceedings called to order on July 29, 2010 did not meet the quorum 
of membership required to conduct an official meeting of this committee.  Because of the lack of 
quorum, any deliberations, recommendations or outcomes occurring during, or resulting from, 
the meeting will not be provided to CDC for consideration and/or implementation. These meeting 
minutes are part of the official committee record.   The agenda items discussed at this meeting 
may be revisited as needed at a later meeting of the committee. 
The Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS, Viral 
Hepatitis, STD and TB Prevention (NCHHSTP) held a conference call with the CDC/HRSA 
Advisory Committee on HIV and STD Prevention and Treatment (CHAC) on July 29, 2010 from 
2:00-3:00 P.M. EST. The conference call was open to the public. 
Dr. Kevin Fenton is the Director of NCHHSTP and Designated Federal Official of CHAC.  He 
explained that a CHAC Workgroup was convened on July 8, 2010 to discuss CDC’s “Strategic 
Realignment of Funding to Support Priorities and STD Disparities Among Racial and Ethnic 
Minorities.” The three key objectives of the Workgroup were to: 
•	 Identify future opportunities to accelerate impact in health disparities through programs, 
policy, research and public health ethics. 
•	 Make recommendations to CDC regarding the potential use of realigned funding. 
•	 Provide key principles to be considered in the development of a new funding opportunity 
announcement (FOA) for use of the realigned resources. 
Dr. Fenton announced that CDC has been investing a certain amount of resources annually in a 
cooperative agreement with Tuskegee University that ended in September 2009.  As a result, 
the Workgroup was convened to provide CDC with a critical review of the best methods to (1) 
realign the resources to meet the legacy objectives of the investment in bioethics and health 
disparities research and (2) realign the resources to have the greatest impact in the current era 
of funding constraints and continued evolution of NCHHSTP’s infectious diseases. 
During the Consultation on July 8, 2010, the Workgroup drafted a summary report of its 
deliberations that was distributed to all CHAC members.  The overarching purpose of the 
conference call was for the full CHAC membership to review the content of and ratify the 
recommendations contained in the draft report.  Following CHAC’s review and comments on the 
draft report, members of the public participating on the conference call would be given an 
opportunity to make comments. 
Dr. Donna Sweet is the co-Chair of CHAC and chaired the CHAC Workgroup on July 8, 2010.  
She commended the writers of the draft report for their truly spectacular efforts in capturing the 
extensive commentary and discussion by the Workgroup during the Consultation.  Her position 
was that the draft report was an accurate reflection of the Workgroup’s deliberations. 




















Dr. Sweet highlighted the Workgroup’s recommendations based its charge by CDC to address 
four key questions. 
1. 	 What criteria should be used to realign the funds?  The Workgroup’s 
recommendations on “criteria” focused on the following areas:  morbidity, an STD 
Prevention Plan, partnerships, health equity, and public health ethics.  The Workgroup 
selected, but did not rank, its top five criteria for CDC to use in realigning the legacy 
funds: 
•	 Significance and impact of the proposed project in reducing disparities. 
•	 Innovation and novel methods to implement a comprehensive sexual health 
framework that values the diversity of sexual expression. 
•	 An innovative and significant STD Prevention Plan that highlights established 
partnerships. 
•	 Engagement of disproportionately affected communities. 
•	 Accountability of HIV grantees to integrate STD prevention into their programs. 
2. 	 How should these funds be directed to accelerate the impact on STD disparities?
The Workgroup’s recommendations on “accelerating the impact” focused on the 
following areas:  multifaceted intervention strategies, evaluation, innovation, a priority
focus on service and policy interventions, health communications and media 
development, direct funding to community-based organizations (CBOs), engagement of 
Community Health Centers (CHCs), a commitment to health equity and public health 
ethics, community-based participatory research (CBPR), compilation and dissemination 
of “best practices,” and provision for multi-year project periods. 
3. 	 How should CDC ensure that the principles of public health ethics inform and 
guide efforts to reduce STD disparities?  The Workgroup’s recommendations on 
“public health ethics” were in the following areas:  public health ethics plans, “Principles 
of the Ethical Practice of Public Health,” evaluation of public health ethics efforts, and 
public health ethics criteria in the FOA. 
4. 	 What institutional or organizational partnerships should be developed to 
effectively implement strategies to reduce STD disparities among racial/ethnic 
minority groups?  The Workgroup’s recommendations on “partnerships” were in the 
following areas:  institutions with credibility with affected communities and populations, 
majority support to CBOs, efforts to address human sexuality and sexual health, 
Community Advisory Boards, diversity of eligible applicants for the FOA, and an 
emphasis on partnerships. 
At the conclusion of her summary, Dr. Sweet opened the floor for the CHAC members to 
provide comments on the Workgroup’s recommendations. 
In general, CHAC commended the Workgroup on drafting an outstanding, thoughtful sensitive 
and thorough report for CDC to strategically realign funding to support priorities and STD 
disparities among racial/ethnic minorities.  CHAC thanked Dr. Fenton for his excellent
leadership in spearheading this important effort.
In particular, individual CHAC members made a number of comments on the Workgroup’s 
recommendations. 



















•	 Regan Hofmann (POZ Magazine, POZ.com, Smart + Strong):  Ms. Hofmann fully 
supported the Workgroup’s suggestion to address the larger social context of attitudes 
related to sex, sexuality and sexual orientation.  She urged CDC to include language in 
the FOA to encourage applicants to explore new and innovative partnerships beyond the 
traditional STD care and treatment community to achieve this goal. 
QUESTION 2 RECOMMENDATIONS
•	 Evelyn M. Foust, MPH (North Carolina Department of Health and Human Services):  
Ms. Foust expressed grave concerns regarding the Workgroup’s recommendations on 
question 2. She was disheartened by the Workgroup’s observation of “the historical
mistrust of health departments” and its recommendation that “states should not serve as 
a “pass-through” to allocate funds to local communities.”  She supported the concept of 
“direct funding to CBOs,” but she noted that communities have commended state and 
local health departments for their actions and activities.  She was extremely concerned 
that this language and recommendation condemn an entire group of agencies without a 
fair hearing and indicate the inability of states to fairly and equitably allocate funding to
CBOs. Ms. Foust also pointed out that the language appears to divide rather than 
integrate communities and health departments at a critical time when coordinated efforts 
are needed to address health disparities.  She hoped that state and local health 
departments would be eligible to apply for funding so long as the agencies met the FOA 
criteria proposed by the Workgroup (e.g., establishing a Community Advisory Board and 
developing a solid STD Prevention Plan).  She emphasized that in some cases, states 
could appropriately serve as a pass-through to better leverage administrative dollars and 
maximize service dollars. 
Dr. Sweet clarified that the Workgroup’s recommendations in response to question 2 
were not intended to malign state and local health departments, promote divisiveness 
between these agencies and communities, or restrict health departments from applying
for funding. The Workgroup merely stated a fact that communities have a history of 
mistrusting health departments.  However, the Workgroup extensively discussed novel 
and innovative strategies to allocate the realigned funding to enhance trust between 
health departments and communities and reduce disparities in affected populations.
These strategies included establishing new coalitions and normalizing conversations 
related to sex as a natural part of life.
Dr. Fenton added that the Workgroup strongly emphasized the need to develop 
innovative strategies to allocate funds to the most severely affected communities for the 
overall investment to have maximal impact.  Based on this guidance, CDC would explore 
a variety of mechanisms to allocate the realigned funding, such as direct funding to 
CBOs, existing infrastructures, state and local health departments, or innovative 
partnerships. 
•	 Jeanne Marrazzo, MD, MPH (Harborview Medical Center):  Dr. Marrazzo’s position was 
that the Workgroup’s recommendation to use three years as the period of time to 
evaluate outcome measures of decreasing STD incidence rates was optimistic.  To 
resolve this issue, she raised the possibility of using the Workgroup’s recommendation
for grantees to form partnerships to provide high-quality STD services as a surrogate 
measure for STD incidence rates. For example, the engagement of actual implementers 
at clinical and health education levels could be established as a target in the FOA and
also as a surrogate marker for grantees to demonstrate the efficacy and relevance of 





















their collaborations.  Meaningful partnerships with implementers who provide direct 
services to patients, clients or at-risk persons seeking health education would play an 
important role in achieving the goal of accelerating the impact on STD disparities. 
•	 William C. Grace, PhD (National Institutes of Health (NIH), Office of AIDS Research; 
Ex-Officio Member): Dr. Grace confirmed that NIH looks forward to the Workgroup’s 
recommendation for CDC to partner with NIH in funding long-term research on STD 
disparities. 
•	 Regan Hofmann (POZ Magazine, POZ.com, Smart + Strong):  Ms. Hofmann was 
pleased that the Workgroup acknowledged the historical mistrust of health departments 
among communities and proposed strategies to address this issue.  Her position was 
that establishing strong relationships with CBOs to recognize and remediate the problem
would play an important role in improving public perceptions of public health agencies 
and decreasing community mistrust and fear of federal, state and local health officials.  
•	 Antigone Hodgins Dempsey, MEd (Altarum Institute Community Health Systems; 
CHAC Workgroup Member):  Ms. Hodgins Dempsey reiterated the Workgroup’s 
recommendation for CDC to allocate the realigned funding for grantees to conduct 
parallel or “twin” interventions at the same time (i.e., service and policy interventions) in 
order to leverage results.
•	 Edward W. Hook III, MD (University of Alabama at Birmingham, CHAC co-Chair): Dr. 
Hook encouraged CDC to include clearer language on “innovation” in the FOA to ensure 
the Workgroup’s recommendations were accurately reflected and maintained between 
the NCHHSTP level and the CDC Procurement and Grants Office level. 
QUESTION 3 RECOMMENDATIONS
•	 André W. Rawls, JD, PhD (Consultant): Dr. Rawls noted that the Workgroup advised 
CDC to instruct the review panel to evaluate and score applications based on the 
following public health ethics criteria:  “Does the proposed project have the capacity to 
help reduce the incidence of STDs in the populations at risk?”  Dr. Rawls recommended 
that CDC provide the review panel with more details and a clearer definition of 
“capacity.” 
QUESTION 4 RECOMMENDATIONS
•	 Evelyn M. Foust, MPH (North Carolina Department of Health and Human Services):  
Ms. Foust questioned the basis of the Workgroup’s recommendation for health 
departments to be required to allocate “no less than 75%” of their awards to CBOs. 
Dr. Sweet responded that the 75% distribution was agreed to by Workgroup consensus.  
The Workgroup’s position was that this allocation was sufficient for CBOs without being 
extensive or burdensome to health departments. 
•	 Kenneth H. Mayer, MD (Brown University AIDS Program):  Dr. Mayer advised CDC to 
require grantees to partner with federal programs in addition to CBOs and state or local 
agencies. For example, some grantees could be Federally Qualified Health Centers that 
receive federal funding from the Health Resources and Services Administration (HRSA).  
Cross-communication between CDC-STD prevention grantees and HRSA-HIV care
grantees would be extremely important to effectively leverage funds and collaborate with 











CBOs and primary care facilities at the local level.  This approach might lead to the 
creation of model programs that could be replicated through HRSA funding streams. 
•	 André W. Rawls, JD, PhD (Consultant): Dr. Rawls cited the Workgroup’s 
recommendation.  “Applicants should be encouraged to establish partnerships with the 
following entities:  faith-based CBOs, mental health agencies, community college 
networks, the National Medical Association, and Minority HIV/ AIDS Research Initiative 
grantees.” Dr. Rawls urged CDC to place this exact language in the FOA. 
Dr. Fenton made a number of remarks in follow-up to CHAC’s comments and questions.  
Because the draft report accurately reflects the Workgroup’s deliberations, the actual record 
could not be changed.  However, comments, suggestions or concerns made by any of the 
CHAC members during the conference call would be appended to the Workgroup’s final report 
as part of the official record. CDC would consider the Workgroup’s final report with comments 
by the full CHAC membership in developing the FOA. 
In direct response to Ms. Foust’s question, Dr. Fenton clarified that the realigned funding in the 
FOA would only include the annual $2 million cooperative agreement with Tuskegee University 
for legacy activities. The FOA would not include CDC’s $20 million allocation to the Syphilis 
Elimination Effort. 
In direct response to Dr. Mayer’s comments, Dr. Fenton conveyed that the Workgroup 
discussed several opportunities to leverage additional resources, such as health reform; 
investments targeted to community-level prevention initiatives; collaborations with colleagues in 
the CDC National Center for Chronic Disease Prevention and Health Promotion who have 
oversight of Community Transformation Grants; and partnerships with communities receiving 
funding through health reform or the American Recovery and Reinvestment Act. 
In direct response to Dr. Hook’s comment, Dr. Fenton explained that the Workgroup’s 
recommendations on innovation were broad and did not clearly define a process for this effort.  
The Workgroup recommended that CDC make a strong and clear commitment to innovation in 
principle. For example, CDC was advised to review existing interventions and more effectively 
integrate these strategies to support the concept of “combination prevention.”  The Workgroup 
urged CDC to focus on community-driven, community-developed and community-appropriate 
innovation through community participatory approaches.  The Workgroup encouraged CDC to 
improve existing interventions through continuous quality improvement mechanisms. 
Dr. Fenton conveyed that the Workgroup urged CDC to ensure sexual health and STD/HIV 
prevention are included in discussions of investing these resources at the local level.  The 
Workgroup noted that although CHAC has made great advances in encouraging CDC and 
HRSA to integrate prevention, treatment and care resources, stronger efforts are needed to 
combine resources in sexual health, chronic disease prevention and other types of ongoing 
community transformation. 
Dr. Fenton explained that although the funding would be realigned, CDC informed the 
Workgroup of its commitment to incorporate a public health ethics approach into all activities 
supported by these resources in the future.  The Workgroup’s pragmatic recommendations 
would help CDC to base its public health ethics efforts on existing best practices and emerging 
evidence in the field. 

















Dr. Fenton announced that CDC was extremely pleased with the insightful comments and 
recommendations the Workgroup provided during the Consultation.  He highlighted key themes 
from the Workgroup’s deliberations that CDC would particularly consider in developing the FOA. 
•	 All activities that are supported by the realigned funding should be based on sound 
public health ethics. 
•	 The $2 million investment should be targeted to new, innovative and impactful strategies 
to address health disparities, particularly among African American and other minority 
communities in the United States. 
•	 The use, impact and effectiveness of the aligned funding should be rigorously evaluated 
to ensure grantees advance CDC’s health disparities agenda in exciting new directions. 
•	 CBPR approaches should be extensively utilized by engaging communities in 
developing initial concepts to allocate the realigned funding and ensuring accountability 
for the implementation and evaluation of all funded interventions. 
•	 More comprehensive approaches should be adopted to address health disparities.  The 
Workgroup provided extensive commentary on the importance of focusing on sexual 
health, social determinants of health and partnerships.  Collaborations with colleagues in 
the CDC National Center for Chronic Disease Prevention and Health Promotion who are 
overseeing Community Transformation Grants and non-traditional partners outside of
health to address social determinants that are driving the epidemic should be used in
this effort. 
•	 Capacity building within communities, state and local health departments and other 
grantees should be prioritized. 
•	 Accountability should be a critical factor to ensure the realigned funding is targeted to
communities in greatest need and follows the epidemiology. CDC should remain nimble 
and flexible to make mid-course modifications in the realigned funding as needed over 
time. The FOA should acknowledge and maintain pace as the dynamic HIV and STD 
epidemics continue to evolve over time. 
At the conclusion of the discussion between the CHAC and CDC, Dr. Fenton opened the floor 
for members of the public to ask questions or provide comments on the realigned funding. 
•	 Vivian Armstead (South Carolina HIV/AIDS Council):  Ms. Armstead posed two 
questions to CDC. First, where could the public access the Workgroup’s draft summary 
report? Second, would the $2 million FOA cover the entire nation and all three years of 
the funding cycle? 
In response to question 1, Dr. Fenton explained that the Workgroup’s draft report would 
not be distributed to the public.  Comments the CHAC members made during the 
conference call would be incorporated into the document and the final report would be 
available to the public on the CDC.gov website in the very near future.  In response to
question 2, Dr. Fenton clarified that the $2 million investment would be targeted to 
innovation and evaluated based on the impact of the funded projects.  If the evaluation 
process demonstrated success, efforts would be made to scale-up interventions by 
establishing partnerships or building the pool of resources over time.  The FOA would be 
released for competition at the national level, but CDC acknowledges that the $2 million 
investment would be small for the entire country.  As a result, only a certain number of 
jurisdictions would be selected for funding to ensure impact. 
















•	 Julie Davids (Community HIV/AIDS Mobilization Project):  Ms. Davids noted that the 
Workgroup advised CDC to fund long-term research on STD disparities in partnership 
with NIH. She posed two questions to CDC regarding this recommendation.  First, 
would funding be allocated for grantees to establish collaborations to support this 
research effort? Second, should applicants demonstrate linkages between CDC’s
sexual health and STD disparities initiative and existing NIH research? 
Dr. Fenton explained that the Workgroup’s recommendations provided CDC with a 
framework to make progress in developing the FOA.  Some recommendations had 
tremendous granularity, while other recommendations were more high-level and advised 
CDC of future directions.  In this recommendation, the Workgroup emphasized the 
importance of CDC partnering with NIH, exploring innovative strategies to utilize a 
portion of the $2 million investment to leverage additional research dollars from NIH, and 
ensuring that CDC’s initiative does not compete with NIH’s research in this area. The 
Workgroup’s high-level recommendation for CDC to partner with NIH provided an 
overarching intent rather than a specific directive. 
•	 Fredette West (African American Health Alliance; Racial and Ethnic Health Disparities 
Coalition): Ms. West posed four questions to CDC.  First, would the awards be made 
before the end of FY2010 or at another time?  Second, how many awards would be 
made? Third, what would be the funding cycle of the awards?  Fourth, would other 
agencies within the Department of Health and Human Services be encouraged to co­
fund the FOA to expand the investment beyond $2 million? Ms. West noted that the 
Workgroup advised CDC to require grantees to have a history of “working with or within 
racial/ethnic communities.” She recommended a qualification to this language, such as 
“effectively” or “successfully” working with or within racial/ethnic communities. 
Dr. Fenton explained that for legal reasons, he would be unable to provide information 
on the nature, form or content of the FOA.  Participants on the conference call who 
planned to submit an application in response to the FOA might have a competitive 
advantage over persons who did not participate on the conference call.  Dr. Fenton 
responded to the questions that he could legally answer at this time.  CDC plans to 
release the FOA in FY2011.  CDC would develop the content of the FOA based on the 
Workgroup’s final report, including comments and suggestions made by the CHAC 
members during the conference call, and additional input from ongoing consultations.
Dr. Sweet pointed out that the Workgroup’s recommendation on “institutions with 
credibility with affected communities and populations” directly responds to Ms. West’s 
comment. The Workgroup recommended that applicants reflect the target community 
ideally, but the experience and success of the applicant in serving the community should 
take precedence regardless of race/ethnicity or other demographic factors.   
CHAC members who participated on the conference call UNANIMOUSLY RATIFIED the July 8, 
2010 Draft Workgroup Report and the amendments proposed by the CHAC members during the 
conference call. 
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